// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Incidence of Outborn babies referred for Therapeutic Hypothermia in British Columbia who achieve target temperature during transport within 6 hours of life

Phanice M. Okara - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Incidence of Respiratory Syncytial Virus infections in the main pediatric hospital in British Columbia, Canada from September 1st to December 31st, 2021.​

Marina Vineta Paramo - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Increased cerebral tissue fractional oxygen extraction with episodes of peripheral arterial desaturation and bradycardia

Mohamed A. Mohamed - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Laparotomy versus Peritoneal Drainage as Initial Surgical Treatment for Necrotizing Enterocolitis or Spontaneous Intestinal Perforation in Preterm Infants: A Systematic Review and Meta-Analysis

Gonzalo Solis-Garcia - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Necrotizing enterocolitis

Hydroxyzine

Logistic Regression Compared to Machine Learning in Prediction of Neurodevelopmental Outcomes in Preterm Infants: A Population-based Study

Jehier Afifi - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Visual dysfunction

N/A

Long-term healthcare utilization and associated costs after childhood dialysis-treated acute kidney injury

Cal H. Robinson - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

Long-term persistence of bitemporal functional hyperconnectivity during stories listening task in 8- to 12-year-old children born extremely preterm

Maria E. Barnes-Davis - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Management of Pain in Children with Severe Neurological Impairments within a complex care program: A retrospective study

Deena Hassan - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Gabapentin

Maternal and Neonatal Outcomes Following Periviable Premature Rupture of Membranes: A Systematic Review and Meta-Analysis

Maura Helena Ferrari Resende - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Preterm premature rupture of the membranes

N/A

Medical and surgical necrotizing enterocolitis: Characteristics, progression, and outcomes

Maher Shahroor - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Necrotizing enterocolitis

N/A

Multi-center study of high-flow nasal cannula initiation and duration of use in patients admitted for mild to moderate bronchiolitis

Michelle Noelck - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Necrotising Enterocolitis: A Systematic Review of Potential Biomarkers

Alannah E. McMahon - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Necrotizing enterocolitis

N/A

Neonatal antibiotic exposure and the risk of early childhood obesity among South Bronx Pediatric population

Adeola O. Awujoola - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Neonatal Cardiac and Intestinal Complications Associated with Diazoxide

Mounya Duggal - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Diazoxide

Neonatal glycemic control and visual short-term memory at 12 months in very preterm infants: evidence from early continuous glucose monitoring

SILVIA GUIDUCCI - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Neonatal regional outreach education in Quebec – a formal needs assessment

Michael-Andrew Assaad - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Neurodevelopmental Outcomes of Preterm Infants Born <29 weeks with Bronchopulmonary Dysplasia Associated Pulmonary Hypertension: A Multicenter Study

Soumya R. Thomas - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Infant Respiratory Distress Syndrome

N/A

Non-interventional approach to PDA in preterm infants: time to look at the chronic pulmonary hypertension outcome

Audrey Hebert - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Optimal dose of intranasal dexmedetomidine for laceration repair in children: a phase II dose-ranging study using the continual reassessment method

Sarah Meulendyks - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Dexmedetomidine hydrochloride

Outcomes of Extreme Preterm Neonates after Adoption of a Less Invasive Surfactant Administration Method in a Tertiary NICU

Michelle Baczynski - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Preterm premature rupture of the membranes

N/A

Copyright © 2026. QuantiNova All rights reserved